Microvast Holdings, Inc. · NASDAQ:MVST
Microvast — Q3 2026 Earnings Presentation
13 slides from Microvast's earnings presentation, Nov 9, 2026
Slide 1: Microvast Q3 2026
eo one microvast’ Q3 2026
Slide 2: Disclaimer: Forward-Looking Statements
2 Disclaimer Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions with respect to the future and management’s current expectations, involve c
Slide 3: Q3 2026 Overview
3 Q3 2026 Overview Q3 Revenue Q3 Gross Profit & Gross Margin Revenue – Revenue decreased 62.8% Y/Y, primarily driven by a 62.2% reduction in sales volume. The decline reflected weaker sales across Europe and APAC as the result of softer end-market demand for heavy-duty trucks, port equipment, and
Slide 4: Q3 2026 P&L
4 Q3 2026 P&L ($ in thousands) Revenue vs. Prior Year Period Revenue decreased 62.8% year-over-year (“Y/Y”), primarily driven by a reduction in sales volume from approximately 501.7 MWh in 2025 to approximately 189.6 MWh for the same period in 2026. Gross margin decreased to 5.2% compared to 37.
Slide 5: Q3 2026 Revenue by Region
5 Q3 2026 Revenue by Region ($ in thousands) Three Months Ended Sept. 30Revenue by region Y/Y %20252026 -65%38,81013,454APAC -64%77,90727,843Europe -31%6,5704,508USA -63%123,28745,805Total Three Months Ended Sept. 30 Nine Months Ended Sept. 30Revenue by region Y/Y %20252026 -51%136,51967,202APAC -30
Slide 6: Cash Flow Statement
6 Cash Flow Statement ($ in thousands) Operating Cash Flow Net cash used in our operating activities was $65.4 million for the nine months ended September 30, 2026, compared to $59.5 million in cash generated by operating activities in the same period in 2025. The changes in our operating assets
Slide 7: Technology Update
eo one microvast’ TECHNOLOGY UPDATE
Slide 8: All-Solid-State Battery Update: Electrochemical Performance & Bipolar Integration
8 Note: The results presented are preliminary, early-stage R&D prototype data obtained under limited laboratory or test conditions. They are not commercial qualification results and remain subject to further validation, repeat testing, scale-up, customer qualification, manufacturing readiness and ca
Slide 9: All-Solid-State Battery Update: Silicon–Sulfur Chemistry & Multilayer Architecture
9Note: The results presented are preliminary, early-stage R&D prototype data obtained under limited laboratory or test conditions. They are not commercial qualification results and remain subject to further validation, repeat testing, scale-up, customer qualification, manufacturing readiness and cap
Slide 10: Outlook: Preserve liquidity and address near-term debt maturities
10 Preserve liquidity, address near-term debt maturities and stabilize operations. Substantial doubt about our ability to continue as a going concern has not been alleviated. Outlook In light of the uncertainty regarding our liquidity position, our ongoing discussions with our lenders regarding the
Slide 11: Appendix
eo one microvast’ APPENDIX
Slide 12: Non-GAAP Reconciliations
12 Non-GAAP Reconciliations ($ in thousands) Nine Months Ended Sept. 30Three Months Ended Sept. 30 2025202620252026 331,117193,679123,28745,805Revenues (205,242)(135,311)(72,151)(34,092)Cost of revenues (4,724)(11,067)(4,724)(9,346)Write-down for obsolete inventories 121,15147,30146,4122,367Gross pr
Slide 13: Non-GAAP Reconciliations
13 Non-GAAP Reconciliations ($ in thousands) Nine Months Ended Sept. 30Three Months Ended Sept. 30 2025202620252026 (45,757)(40,577)(1,489)(76,800)Net loss (GAAP) 91,002(58,001)12,641-Changes in fair value of warrant and convertible loan* 2,2772,614728764Non-cash settled share-based compensation* 47